Actively Recruiting
NeuroPathways Intervention for Brain Tumor Patients
Led by Massachusetts General Hospital · Updated on 2025-12-17
50
Participants Needed
1
Research Sites
178 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This goal of this study is to test an information and support intervention for patients with malignant (or "high-grade") brain tumors. This study was developed to help patients cope after a brain tumor diagnosis. The main question this study aims to answer is whether this intervention (which includes access to an information guide and one-on-one coaching sessions) is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in the coaching sessions, use the guide as desired, and complete a small group of short surveys at three different points in time; some participants will be asked to share feedback via exit interviews.
CONDITIONS
Official Title
NeuroPathways Intervention for Brain Tumor Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 or older
- Patient at Massachusetts General Hospital Cancer Center
- Diagnosed with a primary malignant brain tumor within 6 weeks
- Able to speak and read English
You will not qualify if you...
- Unable to provide informed consent due to neurological issues such as severe cognitive impairment, dementia, or moderate-to-severe receptive aphasia
- Considered inappropriate to approach by the patient's oncologist or study principal investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States, 02114
Actively Recruiting
Research Team
D
Deborah A Forst, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here